Pfizer announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase...
diarrhea
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with...
Across the Western world, the prevalence of these chronic and serious conditions, which have no cure, is...
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating...
The Ebola virus surface glycoprotein (blue) is shown bound by protective antibodies mAb114 (pink/white) and mAb100 (purple/white)....
This holiday season, while you’re busy decorating, cooking, and wrapping gifts, remember to watch out for holiday...
AbbVie, a global biopharmaceutical company, announced results of a Phase 2, open label trial studying investigational compound...
The U.S. Food and Drug Administration granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated...
The U.S. Food and Drug Administration approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF).
The U.S. Food and Drug Administration approved Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF)....